Health Glance
Mylan N.V., makers of the anti-allergic reaction EpiPen, announced programs Thursday to lower the device's cost after U.S. senators expressed outrage at the price increase.
The single-use auto-injection pens, used as dispensers of the medicine epinephrine in emergencies resulting from food allergies, were created by Merck Group in the 1970s, and were acquired by Mylan in 2007. A price increase, from $57 per pen in 2007 to about $500 per pen today, drew the anger, earlier this week, of four U.S. senators who asked Mylan for an explanation.
EpiPen maker offers patients $300 savings cards
Could superbugs become deadlier than cancer?
Drug-resistant infections kill hundreds of thousands of people every year.
That number could soar to as many as 10 million a year by 2050 unless the world acts now. That is the warning from British researchers about drug-resistant bacteria.
For the first time, the researchers have set out what needs to be done to tackle the rise of so-called superbugs.
Overuse of antibiotics is raising the prospect of a future where routine operations will become too dangerous for doctors to perform. And a simple infection could leave you fighting for your life.
Supreme Court upholds $25 million punitive damages against Philip Morris USA
The Supreme Court has rejected Philip Morris USA's appeal of a $25 million punitive damages award to the family of a dead smoker in Oregon.
The justices on Monday are leaving in place a state appeals court ruling that likened the cigarette maker's role in smoker Michelle Schwarz's death to manslaughter under Oregon law, had the case been pursued in criminal court.
TVNL Comment: Reminder: this is the only product that - if used as directed - will kill you. The product has no purpose other than to addict the user. And yet, it is freely available to all the youngsters who are the primary target to replace the nearly half million Americans who die of smoking-related illnesses every year.
Report: hundreds of US hospitals follow Catholic rules on reproductive care
When she was 22 weeks pregnant, Mindy Swank began to bleed. She had known for nearly two weeks that she was miscarrying – and in such a way that she was at risk for infection.
But the Catholic hospital near her home had refused to induce labor, apparently believing that doing so would violate its ban on abortion. And on this morning, the bleeding made no difference. The hospital sent her home – and then again and again, for five more weeks until she began severely hemorrhaging at week 27. Then, they induced her labor.
Cost for new oral cancer drugs skyrocketed in last decade
A new drug for cancer introduced in 2014 costs about six times the price of a new drug in 2000, with the cost of many other drugs to treat the disease increasing in price significantly during that time, according to a new study.
Researchers at the University of North Carolina found the skyrocketing prices line up with changes in health insurance making patients responsible for more of the cost and potentially put people in the position of not being able to afford treatment.
What’s for Breakfast? How About Some Monsanto Weed Killer?
Just how much of Monsanto’s most popular weed killer are you eating every morning for breakfast?
In an unsettling report released Tuesday by the Alliance for Natural Health, the nonprofit advocacy group details the results of a study that shows a host of breakfast foods—from cereal to eggs to coffee creamer—contain residues of glyphosate, the chemical herbicide more commonly known by Monsanto’s trade name for it, Roundup.
The report comes one year after the cancer-research arm of the World Health Organization made headlines by classifying glyphosate, which has long been regarded by U.S. regulators as posing little risk to public health, as a probable human carcinogen.
A subtype of thyroid tumor isn’t cancer after all
People diagnosed with a particular type of thyroid cancer and aggressively treated for it actually didn’t have cancer after all.
That’s the conclusion of 24 endocrinology pathologists from seven countries empaneled by the University of Pittsburgh School of Medicine to reconsider the diagnosis and treatment of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma.
More Articles...
Page 23 of 234
